STOCK TITAN

Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Outset Medical (Nasdaq: OM), a medical technology company focused on dialysis innovation, has scheduled its fourth quarter and full-year 2024 financial results announcement for Wednesday, February 19, 2025, after market close. The company will host a conference call at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on the same day.

Chair and CEO Leslie Trigg and CFO Nabeel Ahmed will lead the discussion of financial and operating results. Interested participants can register online to receive dial-in details and a unique pin. A live and archived webcast will be available on the company's investor relations website.

Outset Medical (Nasdaq: OM), un'azienda tecnologica medica focalizzata sull'innovazione della dialisi, ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per mercoledì 19 febbraio 2025, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica alle 14:00 ora del Pacifico (17:00 ora dell'Est) lo stesso giorno.

Il presidente e CEO Leslie Trigg e il CFO Nabeel Ahmed guideranno la discussione sui risultati finanziari e operativi. I partecipanti interessati possono registrarsi online per ricevere i dettagli per il collegamento e un codice PIN unico. Un webcast in diretta e registrato sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda.

Outset Medical (Nasdaq: OM), una empresa de tecnología médica centrada en la innovación en diálisis, ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año completo 2024 para el miércoles 19 de febrero de 2025, después del cierre del mercado. La empresa realizará una conferencia telefónica a las 2:00 p.m. hora del Pacífico (5:00 p.m. hora del Este) ese mismo día.

La presidenta y CEO Leslie Trigg y el CFO Nabeel Ahmed liderarán la discusión sobre los resultados financieros y operativos. Los participantes interesados pueden registrarse en línea para recibir detalles de la llamada y un PIN único. Una transmisión web en vivo y archivada estará disponible en el sitio web de relaciones con inversores de la empresa.

아우트셋 메디컬 (Nasdaq: OM), 투석 혁신에 중점을 둔 의료 기술 회사가 2025년 2월 19일 수요일에 2024년 4분기 및 전년도 재무 결과 발표를 예정하고 있습니다. 시장 마감 후에 발표할 예정입니다. 이날 오후 2시 태평양 시간(동부 시간 오후 5시)에 컨퍼런스 콜이 열릴 예정입니다.

회장 겸 CEO인 레슬리 트리그와 CFO인 나빌 아흐메드는 재무 및 운영 결과에 대한 논의를 이끌 것입니다. 관심 있는 참가자는 온라인으로 등록하여 전화 참여 세부정보와 고유 핀을 받아볼 수 있습니다. 회사의 투자자 관계 웹사이트에서 실시간 및 아카이브된 웹캐스트를 볼 수 있습니다.

Outset Medical (Nasdaq: OM), une entreprise de technologie médicale axée sur l'innovation en dialyse, a programmé l'annonce de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour le mercredi 19 février 2025, après la clôture du marché. L'entreprise organisera une conférence téléphonique à 14h00, heure du Pacifique (17h00, heure de l'Est) le même jour.

La présidente et PDG Leslie Trigg et le CFO Nabeel Ahmed dirigeront la discussion sur les résultats financiers et opérationnels. Les participants intéressés peuvent s'inscrire en ligne pour recevoir les détails de connexion et un code PIN unique. Un webinaire en direct et archivé sera disponible sur le site Web des relations investisseurs de l'entreprise.

Outset Medical (Nasdaq: OM), ein medizinisches Technologieunternehmen, das sich auf Innovationen im Bereich der Dialyse konzentriert, hat die Bekanntgabe seiner finanziellen Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 für Mittwoch, den 19. Februar 2025, nach Marktschluss angesetzt. Das Unternehmen wird am selben Tag um 14:00 Uhr Pacific Time (17:00 Uhr Eastern Time) eine Telefonkonferenz abhalten.

Die Vorsitzende und CEO Leslie Trigg sowie CFO Nabeel Ahmed werden die Diskussion über die Finanz- und Betriebsergebnisse leiten. Interessierte Teilnehmer können sich online registrieren, um Dial-in-Details und eine einzigartige PIN zu erhalten. Ein Live- und Archiv-Webcast wird auf der Investor Relations-Website des Unternehmens verfügbar sein.

Positive
  • None.
Negative
  • None.

SAN JOSE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full-year 2024 after the close of trading on Wednesday, February 19, 2025.

On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details
The conference call will begin at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on Wednesday, February 19, 2025. Those interested in joining the conference call may do so by registering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contact
Jim Mazzola
Investor Relations
jmazzola@outsetmedical.com


FAQ

When will Outset Medical (OM) release Q4 and full-year 2024 earnings?

Outset Medical will release Q4 and full-year 2024 earnings after market close on Wednesday, February 19, 2025.

What time is Outset Medical's (OM) Q4 2024 earnings call?

The earnings conference call is scheduled for 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on Wednesday, February 19, 2025.

Who will host Outset Medical's (OM) Q4 2024 earnings call?

The earnings call will be hosted by Leslie Trigg, Chair and CEO, and Nabeel Ahmed, CFO.

How can investors access Outset Medical's (OM) Q4 2024 earnings call?

Investors can register online to receive dial-in numbers and a unique pin. A live and archived webcast will also be available on the company's investor relations website.

Outset Medical, Inc.

NASDAQ:OM

OM Rankings

OM Latest News

OM Stock Data

50.48M
52.49M
2.09%
51.52%
12.2%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SAN JOSE